Axicabtagene ciloleucel had durable responses, long-term survival, and consistent outcomes in patients with relapsed or ...
A young British woman who was hit with a devastating stage four cancer diagnosis in her late twenties explains how she ...
Jace Yawnick was diagnosed with primary mediastinal B-cell non-Hodgkin lymphoma in Jan. 2024 at 25 years old. However, Yawnick's first onset of symptoms dates back to Aug. 2023, when he was ...
Two clinical trials testing the antibody loncastuximab tesirine (Zynlonta) showed encouraging results in patients with high-risk forms of two blood cancers—follicular lymphoma and marginal zone ...